Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases

ConclusionsThis retrospective study shows that bevacizumab has efficacy and favorable toxicity in patients with NSCLC and brain metastases and cardiovascular disease might be a risk factor for cerebral toxicity.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research